CEO SUMMARY: Market clearance of the first-ever CLIA waived analyzer for complete blood count and three-part differential tests could cut time-to-answer from days to mere minutes for one of the top 20 tests by volume performed at core laboratories. Developer Sysmex America, Inc., foresees its analyzer as a complement to central labs. Basic diagnostics would […]
FDA CLEARS WAIVED CBC FOR NEAR-PATIENT TESTING
Sysmex Granted First-Ever FDA Clearance of a CLIA-Waived CBC Analyzer for Hematology
- By R. Lewis Dark
- > From the Volume XXIV No. 16 - November 20, 2017 Issue
